Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PL2200 vs IR and EC Aspirin in Type 2 Diabetes
NCT01515657Phase 3Completed
- Sponsor
- PLx Pharma Inc.
- Start
- Jan 2012
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pl-2200 in thrombosis, sponsored by PLx Pharma Inc.. Started Jan 2012; status: completed.
02
Drugs
pl-2200
03
Conditions
thrombosis
Beyond the preview
Go deeper on NCT01515657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01515657.